A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo-controlled first-in-human and first-in-patient trials.
A novel dual glucagon-like peptide and glucagon receptor agonist, SAR425899: results of randomized, placebo-controlled first-in-human and first-in-patient trials